Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J1325 |
Short Description | Epoprostenol injection |
Long Description | Injection, epoprostenol, 0.5 mg |
Pricing indicator | 51 |
Coverage code | D |
ASC payment group code | |
BETOS2 code | O1E |
Action code | N |
Type of service | 1 |
Effective date | 1998-01-01 |
Date Added | 1998-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
00173051700 | J1325 | Epoprostenol injection | Flolan | GLAXOSMITHKLINE | 0.5 MG | 1 | 1 | 1 | 1 |
00173051900 | J1325 | Epoprostenol injection | Flolan | GLAXOSMITHKLINE | 0.5 MG | 1 | 1 | 3 | 3 |
00703198501 | J1325 | Epoprostenol injection | Epoprostenol | SICOR PHARMACEUTICALS, INC. | 0.5 MG | 1 | 1 | 1 | 1 |
00703199501 | J1325 | Epoprostenol injection | Epoprostenol | SICOR PHARMACEUTICALS, INC. | 0.5 MG | 1 | 1 | 3 | 3 |
62756005940 | J1325 | Epoprostenol injection | Epoprostenol | SUN PHARMACEUTICAL INDUSTRIES, LTD. | 0.5 MG | 1 | 1 | 1 | 1 |
62756006040 | J1325 | Epoprostenol injection | Epoprostenol | SUN PHARMACEUTICAL INDUSTRIES, LTD. | 0.5 MG | 1 | 1 | 3 | 3 |
66215040201 | J1325 | Epoprostenol injection | Epoprostenol (Veletri) | ACTELION PHARMACEUTICALS US, INC. | 0.5 MG | 1 | 1 | 3 | 3 |
66215040301 | J1325 | Epoprostenol injection | Epoprostenol (Veletri) | ACTELION PHARMACEUTICALS US, INC. | 0.5 MG | 1 | 1 | 1 | 1 |
Drug Details
-
Epoprostenol injection is used to treat certain kinds of pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Epoprostenol may improve the ability to exercise and slow the worsening of symptoms in patients with PAH. Epoprostenol is in a class of medications called vasodilators and platelet-aggregation inhibitors. It works by relaxing the blood vessels, including those in the lungs, and improving blood flow.